<code id='B8F0B754A7'></code><style id='B8F0B754A7'></style>
    • <acronym id='B8F0B754A7'></acronym>
      <center id='B8F0B754A7'><center id='B8F0B754A7'><tfoot id='B8F0B754A7'></tfoot></center><abbr id='B8F0B754A7'><dir id='B8F0B754A7'><tfoot id='B8F0B754A7'></tfoot><noframes id='B8F0B754A7'>

    • <optgroup id='B8F0B754A7'><strike id='B8F0B754A7'><sup id='B8F0B754A7'></sup></strike><code id='B8F0B754A7'></code></optgroup>
        1. <b id='B8F0B754A7'><label id='B8F0B754A7'><select id='B8F0B754A7'><dt id='B8F0B754A7'><span id='B8F0B754A7'></span></dt></select></label></b><u id='B8F0B754A7'></u>
          <i id='B8F0B754A7'><strike id='B8F0B754A7'><tt id='B8F0B754A7'><pre id='B8F0B754A7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:72398

          What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.

          advertisement

          For more on what we cover, here are the year’s best CEOs; here are the worst; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Novartis is flashing warning signs about its newly acquired myelofibrosis drug
          Novartis is flashing warning signs about its newly acquired myelofibrosis drug

          MollyFerguson/STATCHICAGO—SomethingisoffaboutthewayNovartisistalkingaboutpelabresib,itsnewlyacquired

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Medicare Advantage's lean provider networks lead CMS complaints

          InruralareassuchasBishop,Calif.,elderlypatientsonMedicareAdvantageplanscan'tfindin-networkprovidersw